試す 金 - 無料
5G's Healthcare Implications To Watch For
BioSpectrum Asia
|BioSpectrum Asia August 2021
From remote diagnosis, remote surgery, real-time monitoring to expanded telehealth etc. 5G represents a host of opportunities for healthcare. Let’s look at the possibilities of this technology for healthcare and how it can help bring a paradigm shift in the sector.
Fifth-generation (5G) has gained much importance, development and investment in recent years. This technology has the potential to transform all the components of healthcare, which is especially important as the COVID-19 pandemic has put unparalleled stress on healthcare systems around the world.
Network providers and healthcare institutions are figuring out how best to incorporate this technology into the ecosystem. A new private 5G network from AT&T is helping to revolutionise the way patients and researchers connect at the Lawrence J. Ellison Institute for Transformative Medicine of USC, USA. The on-site 5G network is providing ultra-fast connectivity for patient-centred cancer research, treatment, and wellness education. The Ellison Institute is among the first medical facilities in the USA using 5G to help advance cancer research.
South Korea’s KT Corporation and the Samsung Medical Center (SMC) are working to build a smart hospital. They have jointly developed an innovative, 5G-powered medical service as an initial step to establishing a 5G smart hospital.
Sharing his thoughts, Joe Drygas, AT&T VP of Healthcare Industry Solutions, USA said, “5G has the potential to offer massive connection power, fast speeds and low latency that can help transform how healthcare is delivered. Think remote robotic surgery and quick downloads and transference of massive data files of medical imagery. 5G not only has the capacity to impact the Internet of Medical Things, but it also will help enable medical innovations using augmented reality, virtual reality, artificial intelligence, remote medical learning, remote patient monitoring, and more. Healthcare providers will be able to build an entire ecosystem that creates highly responsive, effective, patient-centric experiences”.
Upgraded Telehealth
このストーリーは、BioSpectrum Asia の BioSpectrum Asia August 2021 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
BioSpectrum Asia からのその他のストーリー
BioSpectrum Asia
Waters launches charge detection mass spectrometry technology
US-based Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterisation for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Chulalongkorn University launches Thailand's first master's programme in Nurse Anesthesia
The Faculty of Nursing, Chulalongkorn University, has officially launched the \"Master of Nursing Science Programme in Nurse Anesthesia\" - the first of its kind in Thailand.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
WHO strengthens coordination for NTD programmes and supply chain delivery
The World Health Organization (WHO), together with health ministries, pharmaceutical donours, implementing partners and technical support platforms, is strengthening coordination for neglected tropical disease (NTD) programmes and supply chain delivery, through three major back-to-back meetings in Geneva.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
All-in-one coronavirus vaccines to save millions in future pandemics
A new study reveals that vaccines designed to protect against a wide range of coronaviruses could dramatically reduce deaths and economic disruption and limit the need for lockdowns in the event of another global coronavirus pandemic.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
NTU in Singapore introduces Master of Science course in Chinese Medicine
From 2026, Nanyang Technological University (NTU) in Singapore will start offering a Master of Science in Chinese Medicine to develop highly skilled postgraduates with advanced expertise in both the theoretical foundations and practical applications of Chinese medicine.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
ProSpecBio launches Activin-A recombinant protein for brain injury research
Israel-based ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, has announced the launch of its latest product: CHO cell-derived recombinant Activin-A, now available for immediate delivery worldwide.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
PAHO publishes guide for designing AI instructions in public health
The Pan American Health Organization (PAHO) has launched a new guide providing practical advice on how to create Artificial Intelligence (AI) prompts that generate reliable, relevant, and culturally appropriate content across diverse contexts.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Prerna launches India's first MicroRNA based blood test for breast cancer screening
Precision RNA Biotech (Prerna), a healthcare startup from Hyderabad, India has announced the launch of Cantel, India's first microRNA-based blood test for breast cancer screening.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr
India-based medtech firm Poly Medicure has announced signing of a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, at an Enterprise Value of Rs 324 crore (EUR 31 million).
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in Japan
Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy Subcutaneous Injection, a once-weekly subcutaneous injection formulation of GLP-1 receptor agonist indicated for the treatment of obesity disease.
1 min
BioSpectrum Asia Nov 2025
Translate
Change font size
